Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 8
Submit an article Journal homepage
278
Views
38
CrossRef citations to date
0
Altmetric
Special Report

Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy

Pedro L Moro Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA. [email protected]
,
Naomi K Tepper Women’s Health and Fertility Branch, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA; Women’s Health and Fertility Branch, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
,
Lisa A Grohskopf Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS A20, Atlanta, GA 30333, USA; Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS A20, Atlanta, GA 30333, USA
,
Claudia Vellozzi Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
&
Karen Broder Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
Pages 911-921 | Published online: 09 Jan 2014

References

  • Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol. Rev. 28, 47–53 (2006).
  • Skowronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine 27(35), 4754–4770 (2009).
  • Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176(4), 463–468 (2007).
  • Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerging Infect. Dis. 14(1), 95–100 (2008).
  • Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374, 451–458 (2009).
  • Siston AM, Rasmussen SA, Honein MA et al.; Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA 303(15), 1517–1525 (2010).
  • Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am. J. Obstet. Gynecol. 205(1), 10–18 (2011).
  • Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 53(RR-6), 1–44 (2004).
  • Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 58(RR-10), 1–8 (2009).
  • Kurz X, Domergue F, Slattery J, Segec A, Szmigiel A, Hidalgo-Simon A. Safety monitoring of influenza A/H1N1 pandemic vaccines in EudraVigilance. Vaccine 29(26), 4378–4387 (2011).
  • Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A (H1N1) 2009 vaccines in the European Union. Euro Surveill. 14(41), 19361 (2009).
  • Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol. 201(6), 547–552 (2009).
  • Varricchio F, Iskander J, Destefano F et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr. Infect. Dis. J. 23(4), 287–294 (2004).
  • Moro PL, Broder K, Zheteyeva Y et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am. J. Obstet. Gynecol. 204(2), 146.e1–146.e7 (2011).
  • Yeager DP, Toy EC, Baker B 3rd. Influenza vaccination in pregnancy. Am. J. Perinatol. 16(6), 283–286 (1999).
  • Deinard AS, Ogburn P Jr. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am. J. Obstet. Gynecol. 140(3), 240–245 (1981).
  • Moro PL, Broder K, Zheteyeva Y et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am. J. Obstet. Gynecol. 205(5), 473.e1–473.e9 (2011).
  • Williams Obstetrics. Cunningham G, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD (Eds). McGraw-Hill Companies Inc., NY, USA (2001).
  • Black S, Eskola J, Siegrist CA et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 374(9707), 2115–2122 (2009).
  • MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl. Vital Stat. Rep. 57(8), 1–19 (2009).
  • Lacroix I, Damase-Michel C, Kreft-Jais C, Castot A, Montastruc JL ; French Association of Regional Pharmacovigilance Centres. 2009 H1N1 influenza vaccines in pregnant women: the French Pharmacovigilance survey. Vaccine 29(7), 1357–1358 (2011).
  • Folkenberg M, Callréus T, Svanström H, Valentiner-Branth P, Hviid A. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010. Vaccine 29(6), 1180–1184 (2011).
  • Parretta E, Ianniello B, Ferrazin F, Rossi F, Capuano A. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. Vaccine 29(20), 3708–3713 (2011).
  • Huang WT, Chen WC, Teng HJ et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women – Taiwan, November 2009–August 2010. PLoS ONE 6(8), e23049 (2011).
  • Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 27(49), 6959–6965 (2009).
  • Rümke HC, Bayas JM, de Juanes JR et al. Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a Phase III safety trial. Vaccine 26(19), 2378–2388 (2008).
  • Pasternak B, Svanström H, Mølgaard-Nielsen D et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 344, e2794 (2012).
  • Fell DB, Sprague AE, Liu N et al.; for Better Outcomes Registry & Network (BORN) Ontario. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am. J. Public Health 102(6), e33–e40 (2012).
  • Oppermann M, Fritzsche J, Weber-Schoendorfer C et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 30(30), 4445–4452 (2012).
  • Omon E, Damase-Michel C, Hurault-Delarue C et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 29(52), 9649–9654 (2011).
  • Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 29(37), 6358–6365 (2011).
  • Lim SH, Lee JH, Kim BC, Jung SU, Park YB, Lee CS. Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns. Vaccine 28(47), 7455–7456 (2010).
  • Mackenzie IS, Macdonald TM, Shakir S et al. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br. J. Clin. Pharmacol. 73(5), 801–811 (2011).
  • Toback SL, Beigi R, Tennis P, Sifakis F, Calingaert B, Ambrose CS. Maternal outcomes among pregnant women receiving live attenuated influenza vaccine. Influenza Other Respi. Viruses 6(1), 44–51 (2012).
  • Toback SL, Falloon J, Ambrose CS. Case reports on maternal and fetal outcomes after exposure to LAIV during pregnancy. Presented at: The 44th National Immunization Conference. Atlanta, GA, USA, 19–22 April 2010.
  • Luteijn JM, Dolk H, Marnoch GJ. Differences in pandemic influenza vaccination policies for pregnant women in Europe. BMC Public Health 11, 819 (2011).
  • Steelfisher GK, Blendon RJ, Bekheit MM et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am. J. Obstet. Gynecol. 204(6 Suppl. 1), S116–S123 (2011).
  • Tamma PD, Steinhoff MC, Omer SB. Influenza infection and vaccination in pregnant women. Expert Rev. Respir. Med. 4(3), 321–328 (2010).
  • Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359(15), 1555–1564 (2008).
  • Eick AA, Uyeki TM, Klimov A et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch. Pediatr. Adolesc. Med. 165(2), 104–111 (2011).
  • Fiore AE, Uyeki TM, Broder K et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. Recomm. Rep. 59(RR-8), 1–62 (2010).
  • Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 60(33), 1128–1132 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.